Loading...

Hepatitis Delta Headwinds And Oncology Uncertainty Will Eventually Support A Modest Recovery

Published
14 Dec 25
Views
0
n/a
n/a
AnalystLowTarget's Fair Value
n/a
Loading
1Y
-11.8%
7D
-2.7%

Author's Valuation

US$1246.0% undervalued intrinsic discount

AnalystLowTarget Fair Value